Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL

被引:33
作者
Angelin, B [1 ]
Parini, P [1 ]
Eriksson, M [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Ctr Metab & Endocrinol, Dept Med, S-14186 Huddinge, Sweden
关键词
atherosclerosis; artificial HDL; cholesterol; apo A-I;
D O I
10.1016/S1567-5688(02)00047-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Reverse cholesterol transport is a complex process, which transfers cholesterol from peripheral cells to the liver for subsequent elimination as bile acids and neutral steroids. Although apo A-I in high density lipoproteins (HDL) is believed to have a crucial role in this process, clinical conditions with very low HDL cholesterol levels appear to maintain normal cholesterol excretion. On the other hand, infusion of 'artificial HDL' in the form of recombinant proapo, A-I (4 g) liposome complexes results in increased fecal steroid excretion, corresponding to a removal of approximate to 0.5 g cholesterol daily for up to 9 days. This occurs without evidence of increased cholesterol synthesis, and could not be reproduced by infusion of liposomes only. These data indicate that stimulation of reverse cholesterol transport may be induced by infusion of 'artificial HDL' in humans, and that a more detailed knowledge of this process may be useful in the treatment of atherosclerosis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 46 条
[1]   Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice [J].
Alam, K ;
Meidell, RS ;
Spady, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :15641-15649
[2]   STUDIES ON THE REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN HUMANS [J].
ANGELIN, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (04) :215-224
[3]   BILE-ACIDS AND PLASMA HIGH-DENSITY-LIPOPROTEINS - BILIARY LIPID-METABOLISM IN FISH EYE DISEASE [J].
ANGELIN, B ;
CARLSON, LA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (02) :157-162
[4]   Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? [J].
Angelin, B ;
Eriksson, M ;
Rudling, M .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :269-274
[5]  
ANGELIN B, 2002, OXFORD TXB ENDOCRINO, P1537
[6]  
ANGELIN B, 1986, ATHEROSCLER REV, V15, P41
[7]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[8]   Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism - Comparison with high density lipoprotein-mediated reverse cholesterol transport [J].
Babiker, A ;
Andersson, O ;
Lund, E ;
Xiu, RJ ;
Deeb, S ;
Reshef, A ;
Leitersdorf, E ;
Diczfalusy, U ;
Bjorkhem, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) :26253-26261
[9]   REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT [J].
BADIMON, JJ ;
BADIMON, L ;
FUSTER, V .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1234-1241
[10]   EFFECT OF BLOOD HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION ON FECAL STEROID-EXCRETION IN HUMANS [J].
BEHER, WT ;
GABBARD, A ;
NORUM, RA ;
STRADNIEKS, S .
LIFE SCIENCES, 1983, 32 (26) :2933-2937